[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100395008":3},{"organization":4,"outcomesModule":7,"designInfo":28,"detailedDescription":31,"studyPopulation":32,"armGroups":33,"interventions":39,"overallOfficials":44,"centralContacts":48,"locations":54,"responsibleParty":161,"collaborators":27,"id":163,"slug":164,"hasResults":165,"nctId":166,"briefTitle":167,"officialTitle":168,"acronym":169,"eligibilityCriteria":170,"healthyVolunteers":165,"sex":171,"minAge":172,"maxAge":173,"enrollmentInfo":174,"targetDuration":27,"studyType":177,"phases":27,"briefSummary":178,"conditions":179,"keywords":27,"overallStatus":57,"whyStopped":27,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":190},{"fullName":5,"class":6},"French Africa Pediatric Oncology Group","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":23,"otherOutcomes":27},[9,13,17,20],{"measure":10,"description":11,"timeFrame":12},"Evaluation of the number of cases with local disease.","By evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis.","5 years",{"measure":14,"description":15,"timeFrame":16},"Evaluation of the number of cases with stage IV disease.","By evaluating the initial clinical reports and later histological reports to confirm the stage.","5 Years",{"measure":18,"description":19,"timeFrame":16},"Evaluating the treatment given.","Comparison of treatment given and recommended treatment.",{"measure":21,"description":22,"timeFrame":16},"Evaluating the follow up after treatment.","How many children alive or dead after treatment",[24],{"measure":25,"description":26,"timeFrame":12},"Why has treatment failed","look at precision of reporting by comparing reports (histological and surgical)",null,{"allocation":27,"interventionModel":27,"interventionModelDescription":27,"primaryPurpose":27,"observationalModel":29,"timePerspective":30,"maskingInfo":27},"COHORT","PROSPECTIVE","The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions.","All children with local Nephroblastoma in all participating units",[34],{"label":35,"type":27,"description":36,"interventionNames":37},"Children with Nephroblastoma","All children coming into the participating units with suspected Nephroblastoma.",[38],"Other: Data collection",[40],{"type":6,"name":41,"description":42,"armGroupLabels":43,"otherNames":27},"Data collection","Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.",[35],[45],{"name":46,"affiliation":5,"role":47},"Fatou Binetou Ms DIAGNE AKONDE, Dr","PRINCIPAL_INVESTIGATOR",[49],{"name":50,"role":51,"phone":52,"phoneExt":27,"email":53},"BRENDA Ms MALLON, MSC","CONTACT","0033142115411","brenda.mallon@gustaveroussy.fr",[55,72,85,101,115,131,146],{"facility":56,"status":57,"city":58,"state":27,"zip":27,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle","RECRUITING","Ouagadougou","Burkina Faso","BF",{"type":62,"coordinates":63},"Point",[64,65],-1.53388,12.36566,{"lat":65,"lon":64},[68,70],{"name":69,"role":51,"phone":27,"phoneExt":27,"email":27},"Sonia Ms Kaboret, Dr",{"name":71,"role":51,"phone":27,"phoneExt":27,"email":27},"kawajo200046@gmail.com",{"facility":73,"status":57,"city":74,"state":75,"zip":27,"country":76,"countryCode":27,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"CHU de Treichville à ABIDJAN","Abidjan","Abidjan Autonomous District","Côte d’Ivoire",{"type":62,"coordinates":78},[79,80],-4.00167,5.35444,{"lat":80,"lon":79},[83],{"name":84,"role":51,"phone":27,"phoneExt":27,"email":27},"Line Guei COUITCHERE, MD",{"facility":86,"status":57,"city":87,"state":27,"zip":88,"country":89,"countryCode":90,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"CUK (Cliniques Universitaires de Kinshasa)","Kinshasa","BP 12 KIN XI","Democratic Republic of the Congo","CD",{"type":62,"coordinates":92},[93,94],15.31357,-4.32758,{"lat":94,"lon":93},[97],{"name":98,"role":51,"phone":99,"phoneExt":27,"email":100},"Aléine BUDIONGO, DR","+(243)99 81 53 133.","albudiongo@gmail.com",{"facility":102,"status":57,"city":103,"state":27,"zip":104,"country":89,"countryCode":90,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"Cliniques Universitaires de Lubumbashi (CUL)","Lubumbashi","BP 1825",{"type":62,"coordinates":106},[107,108],27.47938,-11.66089,{"lat":108,"lon":107},[111],{"name":112,"role":51,"phone":113,"phoneExt":27,"email":114},"Robert LUKAMBA, DR","00(243) 814024633","robertlukamba@yahoo.fr",{"facility":116,"status":57,"city":117,"state":27,"zip":27,"country":118,"countryCode":119,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona","Antananarivo","Madagascar","MG",{"type":62,"coordinates":121},[122,123],47.53613,-18.91368,{"lat":123,"lon":122},[126,129],{"name":127,"role":51,"phone":27,"phoneExt":27,"email":128},"Mbola Mr RAKOTOMAHEFA, Dr","mahefambola@yahoo.fr",{"name":130,"role":47,"phone":27,"phoneExt":27,"email":27},"Mbola RAKOTOMAHEFA, Dr",{"facility":132,"status":57,"city":133,"state":27,"zip":27,"country":134,"countryCode":135,"cosmosGeoPoint":136,"geoPoint":140,"contacts":141},"CHU Gabriel Touré (HGT)","Bamako","Mali","ML",{"type":62,"coordinates":137},[138,139],-7.97522,12.60915,{"lat":139,"lon":138},[142],{"name":143,"role":51,"phone":144,"phoneExt":27,"email":145},"Boubacar TOGO, PROFESSEUR","+223 66 74 29 04","boubacar.togo@gfaop.org",{"facility":147,"status":57,"city":148,"state":148,"zip":27,"country":149,"countryCode":150,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001","Dakar","Senegal","SN",{"type":62,"coordinates":152},[153,154],-17.44406,14.6937,{"lat":154,"lon":153},[157],{"name":158,"role":51,"phone":159,"phoneExt":27,"email":160},"DIAGNE AKONDE Fatou-Binetou, Dr","00(221)77 637 40 63","fabakonde@gmail.com",{"type":162,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100395008","therapeutic-recommendations-for-nephroblastoma-100395008",false,"NCT04423484","Therapeutic Recommendations for Nephroblastoma","Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.","GFANEPHRO20","Inclusion Criteria:\n\nUnilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.\n\n.\n\nExclusion Criteria:\n\nBilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal","ALL","6 Months","18 Years",{"count":175,"type":176},1000,"ESTIMATED","OBSERVATIONAL","The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.",[180],"Nephroblastoma","2026-02-27",{"date":183,"type":184},"2026-03-02","ACTUAL",{"date":186,"type":184},"2020-07-01",{"date":188,"type":176},"2030-12-30",{"name":5,"class":6},7]